STOCKHOLM, Sweden, March 20, 2001 (PRIMEZONE) -- Elekta (SSE:EKTAB) has received orders from major hospitals in the U.S. and Canada valued in total at approximately SEK 100 Million. The orders comprise a number of Elekta Precise Treatment Systems for treatment of cancer including linear accelerator, simulator, and other auxiliary equipment. Furthermore upgrades of hardware and software to existing systems are included. Also included is Leksell Gamma Knife(R) equipment to an American hospital. Deliveries are planned for fiscal year 2001/02.
"We look positively at the development of our North American activities", says Tomas Puusepp, President of Elekta in the U.S. "This is particularly true for our radiation oncology business where we have been entrusted to deliver radiotherapy equipment to some of the most prestigious hospitals in the U.S. and Canada," continues Tomas Puusepp.
"The interest for Leksell Gamma Knife continues to develop positively. At the end of February this year Elekta had installed 148 units all over the world of which 64 systems are in North America, Elekta's largest market for Leksell Gamma Knife", ends Tomas Puusepp.
Elekta is a world-leading supplier of radiation oncology and radiosurgery solutions for precise radiotherapy and neurosurgery. Elekta Precise Solutions include a comprehensive range of non-invasive cancer care and minimally invasive neurosurgey systems including radiosurgery and stereotaxy, backed by a global network of clinical, technical, and financial support services.
...providing Precise Solutions